Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from diabetes

Rates of major illness such as cancer and diabetes to soar by a third by 2040

‘Growth in major illness will place additional demand on all parts of the NHS,’ warns think tank lead Anita Charlesworth

The Independent UK

‘Catastrophic’ forecast shows 9m people in England with major illnesses by 2040

Cases of dementia, diabetes, cancer, depression and kidney disease expected to soar as growing numbers reach old age

The Guardian - UK

WeightWatchers and Noom push Ozempic-like drugs over willpower

Executives promise ‘the demise of dieting.’ Could we be so lucky?

Fortune

From analysis to the latest developments in health,
read the most diverse news in one place.

Timing Of Meals Crucial In Reducing Risk Of Type 2 Diabetes, Study Shows

Late breakfast and dinner increase diabetes risk by 59%, while eating five times a day reduces it, study finds

Zenger

Taking healthcare to the people | The complete Makkalai Thedi Maruthuvam experience in Tamil Nadu

Tamil Nadu's Makkalai Thedi Maruthuvam (MTM) is a path-breaking project providing surveillance and intervention for health needs of its people. It has improved accessibility, early detection of diabetes/hypertension, and reduced out-of-pocket expenditure. Challenges remain, such as human resources, data accuracy, drug delivery, and evaluating outcomes. WHVs, VHNs, and digital tools…

The Hindu

Clinics told to stop prescribing medicines as weight loss drug hits diabetes supply

Government alert warns shortages have ‘serious clinical implications’ for diabetes patients

The Independent UK

IBD Stock Of The Day Novo Nordisk, A Weight-Loss Kingpin, Just Retook Its 50-Day Line

Novo Nordisk stock is Thursday's IBD Stock Of The Day. Shares bounded above their 50-day line, giving investors a new entry.

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

Helping Hand Foundation and Osmania General Hospital collaborate to provide free customised diabetic shoes

HHF & OGH join forces to provide customised diabetic shoes for free to address challenges faced by individuals suffering from diabetes-related foot problems. Shoes, typically priced between ₹2,000-2,500, are procured at a reduced cost of ₹800, making them accessible to patients. 15 pairs of shoes already ordered, demand expected to…

The Hindu

New UK-assisted study shows link between violence and adult diabetes

The University of Kentucky contributed to a new study showing people who experience interpersonal violence as a child or adult have a higher chance of developing adult diabetes

WEKU

Global diabetes cases on pace to soar to 1.3 billion people in the next 3 decades, new study finds

The Research Brief is a short take about interesting academic work.

The Conversation

Is the ‘barefoot-boy summer’ trend bad for your feet? Experts explain

Riffing off 2019’s “hot girl summer” and 2022’s “Adam Sandler summer”, online magazine The Cut has declared 2023 the year of the “barefoot-boy summer”.

The Conversation

The Blazing Weight-Loss Drug Battle: Can Anyone Unseat Undisputed Leaders Novo Nordisk And Lilly?

An overweight world is hungry for obesity treatments, driving big forecasts for weight loss drugs. For now, two pharmaceutical stocks own the market.

Investors Business Daily

Have you been affected by a UK shortage of diabetes and weight loss drugs?

Amid a national shortage of liraglutide and semaglutide, we want to speak to people who rely on these medicines

The Guardian - UK

Common diabetes drug metformin could protect against long COVID

There are no drugs to treat long COVID – a condition that affects around 2 million people in the UK alone – so you can imagine the excitement when a cheap diabetes drug called metformin was shown to decrease the risk of getting the disease.

The Conversation

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

Raven Symone says people shouldn’t use Ozempic for ‘glamazon purposes’

Former Disney star opened up about her family’s history of diabetes

The Guardian - UK

Man with type 1 diabetes smashes record for kayaking around Britain

Dougal Glaisher, 23, paddled 2,000 miles in 40 days, beating previous record by 27 days

Investors Business Daily

The Damaging Report That Sent Weight-Loss Kingpins Novo Nordisk, Eli Lilly Into A Tailspin

Eli Lilly stock and Novo Nordisk stock skidded Tuesday on a report most patients taking weight loss drugs like Wegovy stopped within a year.

The Hindu

Stress on continuing education and technology inputs in diabetes treatment to achieve successful outcomes

Finance Minister K.N. Balagopal has stressed the need for prioritising diabetes research in view of the significant burden of diabetes on society, both in terms of health-care costs and the well-being of individuals

Get all your
news in one place.

100’s of premium titles.
One news app.

The Conversation

Ozempic shortages in the UK may last until 2024 – here’s why

A global shortage means some people with diabetes are struggling to access the drug semaglutide, which is sold under the brand name Ozempic.

Wales Online

Investigation into risk of suicidal and self-harm thoughts among users of Wegovy, Saxenda and other weight loss jabs

It will also look at one used to for type 2 diabetes

Dynamite News

Study finds how deep-sleep brain waves predict blood sugar control

Researchers have known that a lack of quality sleep can increase a person's risk of diabetes. Read further on Dynamite News:

The Guardian - UK

‘It’s naive to think this is in the best interests of the NHS.’ How Big Pharma’s millions are influencing healthcare

Observer investigation shows drug company money flows through the NHS, raising questions about conflict of interest

The Guardian - UK

Revealed: pharma giants pour millions of pounds into NHS to boost drug sales

Observer investigation raises concerns about the influence of drugs companies in shaping patient care in services that use their products

Wales Online

Diabetes drug could provide effective treatment for Parkinson's

According to Parkinson’s UK, the drug – NLX-112 – offers hope that a new multi-faceted treatment could be in reach

Daily Mirror

'New drugs could burn off excess fat and lead to obesity treatments to control diabetes'

Dr Miriam Stoppard shares groundbreaking work from the universities of East Anglia and Cambridge that could help develop medication to burn off excess calories from fat and sugar, which could combat obesity and related diseases

1 … 27 28 29 30

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.